Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NBLUD
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2017089895A1 ADC73
|
|||||
| Synonyms |
WO2017089895A1 ADC73
Click to Show/Hide
|
|||||
| Organization |
LegoChem Biosciences, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Glioblastoma [ICD11:2A00]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Structure |
|
|||||
| Antibody Name |
Depatuxizumab
|
Antibody Info | ||||
| Antigen Name |
Epidermal growth factor receptor variant III (EGFRvIII)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin F
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
WO2017089895A1_ADC73 linker
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.